Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Beat Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $8.13 per share, beating the Zacks Consensus Estimate of$ 5.74 per share. This compares to earnings of $6.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +41.64%. A quarter ago, it was expected that this drugmaker would post a loss of$ 6.12 per share when it actually produced a loss of $8.25, delivering a surprise of -34.8%.Over the last four quarters, the comp ...